PARP10 and ovarian carcinoma: Thus, we next assessed the effect of ALYREF on the stability of PARP10 mRNA in cells treated with actinomycin D. The results indicated that knocking down ALYREF decreased the stability of PARP10 mRNA in ovarian cancer cells (Fig. 4E).